Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Tango Therapeutics (TNGX) Return on Capital Employed (2021 - 2025)

Tango Therapeutics has reported Return on Capital Employed over the past 5 years, most recently at 0.08% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.08% for Q4 2025, up 42.0% from a year ago — trailing twelve months through Dec 2025 was 0.08% (up 42.0% YoY), and the annual figure for FY2025 was 0.06%, up 39.0%.
  • Return on Capital Employed for Q4 2025 was 0.08% at Tango Therapeutics, up from 0.54% in the prior quarter.
  • Over the last five years, Return on Capital Employed for TNGX hit a ceiling of 0.08% in Q4 2025 and a floor of 0.73% in Q2 2025.
  • Median Return on Capital Employed over the past 5 years was 0.31% (2023), compared with a mean of 0.32%.
  • Peak annual rise in Return on Capital Employed hit 42bps in 2025, while the deepest fall reached -35bps in 2025.
  • Tango Therapeutics' Return on Capital Employed stood at 0.12% in 2021, then crashed by -129bps to 0.28% in 2022, then decreased by -10bps to 0.31% in 2023, then plummeted by -59bps to 0.49% in 2024, then surged by 85bps to 0.08% in 2025.
  • The last three reported values for Return on Capital Employed were 0.08% (Q4 2025), 0.54% (Q3 2025), and 0.73% (Q2 2025) per Business Quant data.